Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 12:02 pm Purchase |
2009-02-28 | 13G | Calithera Biosciences, Inc. CALA |
PRIMECAP MANAGEMENT CO/CA/ | 512,675 14.530% |
9,600 (+1.91%) |
Filing History |
| 2021-02-11 5:25 pm Sale |
2020-12-31 | 13G | Calithera Biosciences, Inc. CALA |
BIOTECHNOLOGY VALUE FUND L P | 218,062 6.200% |
-136,470 (-38.49%) |
Filing History |
| 2021-02-10 10:39 am Purchase |
2020-12-31 | 13G | Calithera Biosciences, Inc. CALA |
The Vanguard Group | 183,735 5.210% |
183,735 (New Position) |
Filing History |
| 2021-01-28 5:55 pm Purchase |
2020-12-31 | 13G | Calithera Biosciences, Inc. CALA |
BlackRock Inc. BLK |
283,420 8.000% |
78,045 (+38.00%) |
Filing History |
| 2021-01-25 4:06 pm Purchase |
2021-01-13 | 13G | Calithera Biosciences, Inc. CALA |
ADAGE CAPITAL PARTNERS GP L.L.C. | 200,000 5.670% |
125,000 (+166.67%) |
Filing History |
| 2020-10-08 7:01 pm Purchase |
2009-02-28 | 13G | Calithera Biosciences, Inc. CALA |
PRIMECAP MANAGEMENT CO/CA/ | 503,075 14.260% |
28,675 (+6.04%) |
Filing History |
| 2020-05-26 4:56 pm Sale |
2020-05-21 | 13G | Calithera Biosciences, Inc. CALA |
BIOTECHNOLOGY VALUE FUND L P | 354,532 10.100% |
-123,450 (-25.83%) |
Filing History |